Search results
Minerva Neurosciences (NASDAQ:NERV) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a report issued on Sunday morning. The brokerage issued a sell rating on ...
Ultra-processed foods linked to higher cognitive decline, stroke risk
MedicalNewsToday via AOL· 5 days agoA new study published this week from researchers at Massachusetts General Hospital in Boston finds...
Another View | The Columbian: FAA reauthorization win for travelers, Congress
The Daily News· 14 hours agoDespite well-documented troubles at Boeing, a series of harrowing incidents and growing passenger...
Business Cycle: Honorees recognized at TechNite awards
Roanoke Times· 7 days agoWith hundreds attending its annual gala, the Roanoke-Blacksburg Technology Council issued the...
Documents of Mundanity | Doreen St. Félix
New York Review of Books· 14 hours agoWhile I was preparing for this interview, there was a problem with The New Yorker’s website; when I searched “Doreen St. Felix,” I got what seemed to be...
What Our Brains Know About Stocks—But Won’t Tell Us
The Wall Street Journal· 4 days agoThe investors weren’t told the names of the stocks and said they didn’t recognize them. The set of information the investors...These results are...
SageView Advisory Group LLC Acquires 718 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 14 hours agoSageView Advisory Group LLC boosted its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 30.6% in the fourth quarter, according to the company in its most recent Form 13F filing with ...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 3 days agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 5 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued on Wednesday, Benzinga reports.
Novant launches sale-leaseback initiative with Chicago groups
Winston-Salem Journal· 6 days agoNovant Health said it has commenced a real estate sale and leaseback initiative likely to be worth...
